The Russian Ministry of Health approved circulation of Evusheld, a COVID-19 prophylaxis drug by AstraZeneca, on the territory of the country, according to the...
The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research.
As we have throughout the COVID-19 pandemic,...
The St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical-Biological Agency (FMBA) has filed an application with the Health Ministry...
Longidaza®, developed in Russia, received a patent in India. This was reported by the company "Petrovax". Thus, Longidasa, which already has patents in a...
The resident of SEZ Technopolis Moscow plans to complete the construction of a new large pharmaceutical production at Alabushevo site this year. The enterprise...